issue3_2025_247BIOPHARMA

3 TWENTYFOURSEVENBIOPHARMA Issue 3 / October 2025 CONTENTS PROCOS SpA 66 Interview CPHI FRANKFURT 70 CPHI personal stories roundtable PHARMATECH ASSOCIATES 76 Predictive modelling: the new imperative for pharmaceutical innovation SONIA RASI Financial Director 66 PROCOS SpA Interview PATRICIA LUHRS Client Services & Account Manager CLARA USANNA Senior Sales Manager – Europe, Latam, Africa, India & Oceania ADRAGOS PHARMA 82 The importance of ioequivalence studies for successful new generics BIOTECH 86 Military sponsored trials rowth is picking up the slack of weak VC funding – with non-military applications quickly emerging

RkJQdWJsaXNoZXIy MjY2OTA4MA==